IGLV1-44

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, IGLV1-44 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated IGLV1-44 data layer compared with 2 for mutation status and 8 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher IGLV1-44 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated IGLV1-44 expression acts as an unfavorable survival marker, although some lineages such as HNSC and SKCM show a favorable association.

HNSC, SKCM, and BRCA are the cancer types where IGLV1-44 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
HNSCDFSMedianAll0.7510.639<.001145view →
SKCMOSMedianAll0.4270.258<.00196view →
BRCADFSTertileAll0.9690.920<.00179view →
LIHCDFSTertileAll0.5960.421<.00151view →
UCECOSMedianIII,IV0.7220.398.00240view →
OVDFSQuartileII,III,IV0.4400.311.00328view →
SARCDFSMedianAll0.6370.431.00328view →
COADDFSTertileIII,IV0.7250.362.02424view →
KIRPOSMedianAll0.5800.892.00322view →
GBMOSQuartileAll0.3150.504.00118view →
KIRCDFSTertileAll0.4740.717.00915view →
CESCDFSQuartileAll0.8480.661.00514view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

Exploration